Kelly Manning

Staff Scientist

Emory University
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (8)

Background: Maternal immunization provides vaccine-specific immunity to the infant via breast milk. Multiple studies have reported the presence of SARS-CoV-2 antibodies in human breast milk (HBM) from infected and/or vaccinated women. However, there is limited information on the analytical performance, consistency, and quality of the methods used. Standardized and rigorous assays are needed to meet clinical study endpoints and for comparisons across studies. Methods: We optimized high-throughput multiplex immunoassays for quantification of SARS-CoV-2 immunoglobulin (Ig)G and IgA in HBM and determined antibody levels in HBM samples from 236 SARS-CoV-2 vaccinated (infected and non-infected) and 50 pre-pandemic (unexposed) lactating women. Additionally, SARS-CoV-2 neutralizing activity was examined in a subset of 75 SARS-CoV-2 HBM from vaccinated (infected and non-infected) women using live virus focus reduction neutralization and pseudovirus assays. Concordance between SARS-CoV-2 binding and live virus neutralization outcomes was examined. Results: The multiplex SARS-CoV-2 assays had adequate analytical sensitivity, repeatability, precision, and assay linearity and were reliable for quantification of IgG and IgA in HBM. Positivity thresholds for Spike- and Nucleocapsid-specific IgG and IgA were established; IgG discriminated positive/negative SARS-CoV-2-immune HBM with high sensitivity and specificity, while IgA reactivity overlapped. A strong correlation was observed between live SARS-CoV-2 and pseudovirus neutralization activity. HBM Spike IgA and neutralization titers were highly correlated. Conclusions: SARS-CoV-2 binding and neutralizing antibody activity in HBM was determined using standardized and rigorous assays. HBM positivity cutoff values for SARS-CoV-2 vaccination and infection were established. The methods and approach described here could be applied to other pathogens and mucosal secretions.

Year:

2025

Supplementary Table 2: Antibodies used for immune-phenotyping (CyTOF analysis). Supplementary Table 3: Antibodies used for flow cytometry. Supplementary Table 4: Antibodies used for AIM Assay (CyTOF analysis).

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (21)

Rafi Ahmed

Emory University School of Medicine

UNITED STATES
View details

Meagan Deming

Assistant Professor

University of Maryland Center for Vaccine Development

UNITED STATES
View details

Flor Munoz

Associate Professor

Baylor College of Medicine

UNITED STATES
View details

Jonathan Kaufman

Winship Cancer Institute of Emory University

UNITED STATES
View details

Alberto Moreno

Emory University

UNITED STATES
View details

Renee Julia Manalo

Emory University

UNITED STATES
View details

Marcela F. Pasetti

University of Maryland School of Medicine

UNITED STATES
View details

Barbra Richardson

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Mehul S. Suthar

Emory University School of Medicine

UNITED STATES
View details

Sagar Lonial

-

UNITED STATES
View details

Colin Swenson

Associate Professor

Emory University

UNITED STATES
View details

Craig Hofmeister

Professor

Emory University

UNITED STATES
View details

Rafi Ahmed

Emory University School of Medicine

UNITED STATES
View details

Bryan Berube

Seattle Children's Research Institute

UNITED STATES
View details

Ajay K. Nooka

Professor

Emory University

UNITED STATES
View details

Courtney Olson-Chen

Associate Professor

University of Rochester Medical Center

UNITED STATES
View details

Nisha Joseph

Associate Professor

Winship Cancer Institute of Emory University

UNITED STATES
View details

Madhav V. Dhodapkar

-

UNITED STATES
View details

Alessandro Sette

Professor and Member

La Jolla Institute for Immunology

UNITED STATES
View details

Kavita M. Dhodapkar

Emory University

UNITED STATES
View details

Jeffrey Switchenko

Emory University

UNITED STATES
View details